Heilicobacter pylori infection
Conditions
Interventions
Sponsors
Department of Gastroenterology, Run Run Shaw Hospital of Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Voluntarily sign the informed consent; 2. The age is more than 18 years old, men and women are not limited; 3. Patients who were Hp positive without anti-bacterial treatment;
Exclusion criteria
Exclusion criteria: 1. Patients who have used antibiotics or bismuth agent within 4 weeks; Patients who had used antacids (H2 antagonists or proton pump inhibitors), prokinetic drugs (mosapride or doperidone, etc.) and gastric mucosa protectants (tipredone, sucralose, rabapet, etc.) in the previous 2 weeks; 2. Patients with serious lesions in important organs of the body (heart, liver, kidney, lung, etc.); 3. Patients diagnosed with gastric cancer by gastroscopy or other examinations; 4. Pregnant and nursing women; 5. Unable to follow visitors or allergic to this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hp eradication rate;Incidence of adverse reactions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptom remission rate; | — |
Countries
China
Contacts
Public ContactHu Weiling
Department of Gastroenterology, Run Run Shaw Hospital of Zhejiang University School of Medicine
Outcome results
None listed